Alaa Shalaby, MD

Veterans Health Foundation

Alaa Shalaby, MD


Dr. Shalaby graduated from Ain Shams University Faculty of Medicine, Cairo, Egypt where he subsequently obtained his Master’s degree in Medicine. He attended medical residency and cardiology programs at Albert Einstein College of Medicine Montefiore Hospital, New York and Creighton University, Omaha, respectively. Training in cardiac electrophysiology was completed at UCLA and the West LA VA Medical Center. Dr. Shalaby is currently director of the cardiac electrophysiology service at the VAPHS providing state of the art diagnostic and treatment modalities for arrhythmic disorders. In a current study funded by the VA competitive pilot project fund, Dr. Shalaby seeks to explore the potential antiarrhythmic effect of chronic vagal stimulation, as a non-pharmacologic intervention, in an infarct model. Dr. Shalaby is Associate Professor of medicine, University of Pittsburgh. Dr. Shalaby’s research interests include novel pharmaceutical and device applications for the prevention, detection and treatment of sudden death, congestive heart failure, sleep disordered breathing and atrial fibrillation. Dr. Shalaby has authored and coauthored close to fifty peer reviewed papers and numerous abstracts in these areas.Dr. Shalaby graduated from Ain Shams University Faculty of Medicine, Cairo, Egypt where he subsequently obtained his Master’s degree in Medicine. He attended medical residency and cardiology programs at Albert Einstein College of Medicine Montefiore Hospital, New York and Creighton University, Omaha, respectively. Training in cardiac electrophysiology was completed at UCLA and the West LA VA Medical Center. Dr. Shalaby is currently director of the cardiac electrophysiology service at the VAPHS providing state of the art diagnostic and treatment modalities for arrhythmic disorders. In a current study funded by the VA competitive pilot project fund, Dr. Shalaby seeks to explore the potential antiarrhythmic effect of chronic vagal stimulation, as a non-pharmacologic intervention, in an infarct model. Dr. Shalaby is Associate Professor of medicine, University of Pittsburgh. Dr. Shalaby’s research interests include novel pharmaceutical and device applications for the prevention, detection and treatment of sudden death, congestive heart failure, sleep disordered breathing and atrial fibrillation. Dr. Shalaby has authored and coauthored close to fifty peer reviewed papers and numerous abstracts in these areas.